12


/ Press Releases
2018.11
TWi's ANDA of Oxcarbazepine ER Tablet has been tentatively approved by US FDA
2018.10
TWi successfully launches generic Bupropion Hydrochloride ER Tablet in TWi label
2018.09
TWi's ANDA of Diltiazem HCL ER Capsule has been approved by US FDA
2018.04
TWi is marketing Cephelexin Oral Suspension in partnership with a leading Taiwanese manufacturer
2017.12
Court Dismisses Patent Challenge to TWi's Paragraph IV ANDA Filing for a Generic Equivalent to Axiron®